Interleukin-6 gene therapy
Latest Information Update: 06 Dec 2007
Price :
$50 *
At a glance
- Originator Yeda
- Class Cytokine genes; Gene therapies; Interleukins
- Mechanism of Action Natural killer cell stimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer